Elías Campo
Director de l'IDIBAPS i de la FCRBGrup de recerca
- Patologia molecular en neoplàsies limfoides Group leader (R4)
Publicacions destacades
-
Cyclin D1 overexpression induces global transcriptional downregulation in lymphoid neosplasms.
Autors: Albero R, Enjuanes A, Demajo S, Castellano G, Pinyol M, García N, Capdevila C, Clot G, Suárez-Cisneros H, Shimada M, Karube K, López-Guerra M, Colomer D, Beà S, Martin-Subero JI, Campo E, Jares P .Referència: Journal Of Clinical Investigation 2018. -
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Autors: Swerdlow S.H., Campo E., Pileri S.A., Lee Harris N., Stein H., Siebert R., Advani R., Ghielmini M., Salles G.A., Zelenetz A.D., Jaffe E.S..Referència: Blood 2016. -
Landscape of somatic mutations and clonal evolution in mantle cell lymphoma
Autors: Bea, Silvia; Navarro, Alba; Salaverria, Itziar; Martin-Garcia, David; Jares, Pedro; Gine, Eva; Nadeu, Ferran; Conde, Laura; Juan, Manel; Clot, Guillem; Lopez-Guerra, Monica; Moros, Alexandra; Roue, Gael; Aymerich, Marta; Villamor, Neus; Martinez, Antonio; Valera, Alexandra; Amador, Virginia; Hernandez, Luis; Rozman, Maria; Colomer, Dolors; Lopez-Guillermo, Armando; Campo, Elias.Referència: Proceedings Of The National Academy Of Sciences Of The United States Of America 2013.
Projectes destacats
-
Molecular Diagnosis, Prognosis, and Therapeutic Targets in Mantle Cell Lymphoma
Investigador/a principal: Elías Campo GüerriFinançador: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede); National Institut of Health (NHI)Codi: 1P01CA229100Durada: 01/09/2019 - 31/08/2023 -
Single-cell genomics to comprehensively understand healthy B-cell maturationand transformation to chronic lymphocytic leukemia (BCLL@las)
Investigador/a principal: E Campo, H Heyn, JI Martin-Subero, Gut. Ivo, Elias CampoFinançador: European Commission ; IDIBAPS (August Pi Sunyer Biomedical Research Institute), Barcelona, Spain. (Sede)Codi: H2020-ERC-Sy_2018 (810287)Durada: 01/04/2019 - 31/03/2023 -
Functional and Clinical Impact of Genomics Analysis in CLL
Investigador/a principal: Elías Campo GüerriFinançador: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede); Instituto de Salud Carlos IIICodi: PMP15/00007Durada: 01/01/2016 - 30/09/2020 -
EUCANCan: a federated network of aligned and interoperable infrastructures for the homogeneous analysis, management and sharing of genomic oncology data for Personalised Medicine
Investigador/a principal: Elías Campo GüerriCodi: EUCANCANCERDurada: 01/01/2019 - 31/12/2022 -
La Medicina Personalitzada a Catalunya-Càncer (MedPerCan). Estudi pilot sobre l'impacte de l'anàlisi genòmica en la pressa de decisions en oncologia.
Investigador/a principal: Elías Campo GüerriCodi: SLT002/16/00374Durada: 01/01/2017 - 31/12/2019